Literature DB >> 10418580

Bronchiectasis: the 'other' obstructive lung disease.

V Mysliwiec1, J S Pina.   

Abstract

Bronchiectasis belongs to the family of chronic obstructive lung diseases, even though it is much less common than asthma, chronic bronchitis, or emphysema. Clinical features of these entities overlap significantly. The triad of chronic cough, sputum production, and hemoptysis always should bring bronchiectasis to mind as a possible cause. Chronic airway inflammation leads to bronchial dilation and destruction, resulting in recurrent sputum overproduction and pneumonitis. Once the diagnosis is confirmed, any potential predisposing conditions should be aggressively sought. The relapsing nature of bronchiectasis can be controlled with antibiotics, chest physiotherapy, inhaled bronchodilators, proper hydration, and good nutrition. In rare circumstances, surgical resection or bilateral lung transplantation may be the only option available for improving quality of life. Prognosis is generally good but varies with the underlying syndrome.

Entities:  

Mesh:

Year:  1999        PMID: 10418580     DOI: 10.3810/pgm.1999.07.607

Source DB:  PubMed          Journal:  Postgrad Med        ISSN: 0032-5481            Impact factor:   3.840


  5 in total

Review 1.  Bronchiectasis.

Authors:  Nick ten Hacken; Huib Kerstjens; Dirkje Postma
Journal:  BMJ Clin Evid       Date:  2008-01-02

Review 2.  Bronchiectasis.

Authors:  Nick Ht Ten Hacken; Huib Am Kerstjens
Journal:  BMJ Clin Evid       Date:  2011-08-16

Review 3.  Bronchiectasis.

Authors:  Cecile Magis-Escurra; Monique He Reijers
Journal:  BMJ Clin Evid       Date:  2015-02-25

4.  The Frequency of Obstructive Sleep Apnea in Patients with Non-cystic Fibrosis Bronchiectasis.

Authors:  Sermin Borekci; Yonca Sekibag; Deniz Ongel Harbiyeli; Benan Musellim
Journal:  Turk Thorac J       Date:  2021-07

5.  Clinical, radiologic, and functional evaluation of 304 patients with bronchiectasis.

Authors:  Mehmet Ali Habesoglu; Aylin Ozsancak Ugurlu; Fusun Oner Eyuboglu
Journal:  Ann Thorac Med       Date:  2011-07       Impact factor: 2.219

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.